SCHEMBL29254651

SCHEMBL29254651

COc1ccc2c(c1)OC(=Cc1ccc(Oc3ccc(C#N)cc3C(F)(F)F)c(OC)c1)C2=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESRRB O95718 1/20 0.57
▸ ESR1 P03372 1/20 0.57
▸ ESRRA P11474 1/20 0.57
▸ ESRRG P62508 1/20 0.57
▸ ESR2 Q92731 1/20 0.57
▸ MAOB P27338 5/20 0.53
▸ STK17B O94768 2/20 0.52
▸ MEN1 O00255 2/20 0.51
▸ POLB P06746 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ CSNK2A2 P19784 1/20 0.51
▸ CSNK2B P67870 1/20 0.51
▸ CSNK2A1 P68400 1/20 0.51
▸ PNLIP P16233 2/20 0.50
▸ PTGS2 P35354 1/20 0.48
▸ HDAC3 O15379 1/20 0.48
▸ HDAC4 P56524 1/20 0.48
▸ HDAC1 Q13547 1/20 0.48
▸ HDAC7 Q8WUI4 1/20 0.48
▸ HDAC2 Q92769 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29254637 0.93 ESRRA (0.57) ESRRBESR1ESRRAESRRGESR2
SCHEMBL29254648 0.91 ESRRA (0.57) ESRRBESR1ESRRAESRRGESR2
SCHEMBL29254644 0.91 CXCL12 (0.59) ESRRBESR1ESRRAESRRGESR2
SCHEMBL29255027 0.91 ESRRA (0.56) ESRRBESR1ESRRAESRRGESR2
SCHEMBL29254664 0.91 MEN1 (0.61) ESRRBESR1ESRRAESRRGESR2
SCHEMBL29254631 0.91 PNLIP (0.61) ESRRBESR1ESRRAESRRGESR2
SCHEMBL29255381 0.91 PNLIP (0.55) ESRRBESR1ESRRAESRRGESR2
SCHEMBL29254663 0.90 PNLIP (0.56) ESRRBESR1ESRRAESRRGESR2
SCHEMBL29254633 0.90 STK17B (0.63) ESRRBESR1ESRRAESRRGESR2
SCHEMBL29254650 0.89 MAOB (0.59) ESRRBESR1ESRRAESRRGESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118307504-A Orange ketone derivative or analogue, preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2024-07-09 — — CN disclosed
Send feedback